Trial
NCT01318993
Open-Label Extension Study of GSK1605786A
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Crohn's Disease
Intervention
GSK1605786A
Why stopped
This study was terminated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-09-14